Saturday 17 October 2026 Export SGMT’s income statement to Excel — free account

Sagimet Biosciences Inc.

Sagimet Biosciences Inc.’s revenue for fiscal 2023 (year ended December 2023) was $2.0 million. In the quarter to June 2026, EPS grew 18.8% and free cash flow fell 22.0%, each against the same quarter a year earlier.

8.02 0.15 −1.84%

Follow SGMT

Alert me

Market cap: $574.7M
P/E: 0.0×
Fwd P/E: −2.3×
Dividend yield: —
F-score: n/a
Altman Z: 2.50
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(39.78%)	(38.20%)	(36.04%)	(24.37%)
ROA Full definition →		(38.04%)	(36.89%)	(34.27%)	(23.49%)
ROIC Full definition →		(1,569.06%)	0.00%	0.00%	(205.24%)
Return on Tangible Assets Full definition →		(52.27%)	(45.86%)	(42.48%)	(19.73%)
Free Cash Flow per Share Full definition →		(1.38)	(1.41)	(1.22)	(0.79)
Free Cash Flow Full definition →		(44.84)	(45.65)	(39.72)	(41.72)
Other line items
Cash ROIC Full definition →		(19.00%)	(20.33%)	(19.19%)	(8.41%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.78	0.89	0.91	0.89
Depreciation/Fixed assets Full definition →		0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.38)	(1.41)	(1.22)	(0.79)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly